| An overview of the patterns of prescription opioid use, costs and related harms in A ustralia B Blanch, SA Pearson, PS Haber British journal of clinical pharmacology 78 (5), 1159-1166, 2014 | 155 | 2014 |
| Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: a systematic review JM Langton, B Blanch, AK Drew, M Haas, JM Ingham, SA Pearson Palliative medicine 28 (10), 1167-1196, 2014 | 90 | 2014 |
| Twenty‐five years of prescription opioid use in Australia: a whole‐of‐population analysis using pharmaceutical claims EA Karanges, B Blanch, NA Buckley, SA Pearson British journal of clinical pharmacology 82 (1), 255-267, 2016 | 74 | 2016 |
| The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers L Mellish, EA Karanges, MJ Litchfield, AL Schaffer, B Blanch, BJ Daniels, ... BMC research notes 8 (1), 634, 2015 | 74 | 2015 |
| Discriminating melancholic and non-melancholic depression by prototypic clinical features G Parker, S McCraw, B Blanch, D Hadzi-Pavlovic, H Synnott, AM Rees Journal of affective disorders 144 (3), 199-207, 2013 | 45 | 2013 |
| Does gender influence response to differing psychotherapies by those with unipolar depression? G Parker, B Blanch, J Crawford Journal of Affective Disorders 130, 17-20, 2011 | 41 | 2011 |
| Frequency of reporting of adverse events in randomized controlled trials of psychotherapy vs. psychopharmacotherapy B Vaughan, MH Goldstein, M Alikakos, LJ Cohen, MJ Serby Comprehensive Psychiatry 55 (4), 849-855, 2014 | 37 | 2014 |
| The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: A 12‐week single‐blind randomized study G Parker, B Blanch, A Paterson, D Hadzi‐Pavlovic, E Sheppard, ... Acta Psychiatrica Scandinavica 128 (4), 271-281, 2013 | 21 | 2013 |
| The ‘magic button question’for those with a mood disorder—Would they wish to re-live their condition? G Parker, A Paterson, K Fletcher, B Blanch, R Graham Journal of affective disorders 136 (3), 419-424, 2012 | 20 | 2012 |
| Trends in opioid utilisation in Australia, 2006‐2015: Insights from multiple metrics EA Karanges, NA Buckley, J Brett, B Blanch, M Litchfield, L Degenhardt, ... Pharmacoepidemiology and drug safety 27 (5), 504-512, 2018 | 12 | 2018 |
| To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia? N Gisev, SA Pearson, EA Karanges, B Larance, NA Buckley, S Larney, ... Pharmacoepidemiology and drug safety 27 (5), 550-555, 2018 | 12 | 2018 |
| Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000–2013) B Blanch, NA Buckley, L Mellish, AH Dawson, PS Haber, SA Pearson Drug safety 38 (6), 553-564, 2015 | 12 | 2015 |
| Participant satisfaction with Youth Justice Conferencing P Wagland, B Blanch, E Moore NSW Crime and Justice Bulletins 170, 2013 | 11 | 2013 |
| The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia L Degenhardt, B Blanch, N Gisev, B Larance, S Pearson BMJ open 5 (1), e007030, 2015 | 10 | 2015 |
| A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults SB Ross, K Jones, B Blanch, R Puranik, K McGeechan, A Barratt, ... European heart journal, 2019 | 7 | 2019 |
| Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated N Gisev, SA Pearson, B Blanch, B Larance, T Dobbins, S Larney, ... British journal of clinical pharmacology 82 (4), 1123-1133, 2016 | 7 | 2016 |
| Out of the darkness: the impact of a mood disorder over time G Parker, A Paterson, K Fletcher, M Hyett, B Blanch Australasian Psychiatry 20 (6), 487-491, 2012 | 6 | 2012 |
| The ‘real world’utility of a web‐based bipolar disorder screening measure G Parker, K Fletcher, B Blanch, L Greenfield Acta Psychiatrica Scandinavica 127 (5), 373-380, 2013 | 5 | 2013 |
| Looking forward and looking back: the balancing act in new drug user designs for pharmacoepidemiological research B Blanch, B Daniels, M Litchfield, SA Pearson Pharmacoepidemiology and drug safety 24 (10), 1117-1119, 2015 | 4 | 2015 |
| Is cognitive behaviour therapy of benefit for melancholic depression? D Gilfillan, G Parker, E Sheppard, V Manicavasagar, A Paterson, B Blanch, ... Comprehensive psychiatry 55 (4), 856-860, 2014 | 4 | 2014 |
